Literature DB >> 7665907

Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line.

C Esaki1, M Seishima, T Yamada, K Osada, Y Kitajima.   

Abstract

The precise mechanism for acantholysis after pemphigus IgG binds to the cell surface is as yet unknown, although involvement of proteinases such as plasminogen activator (PA) has been suggested. We previously reported that pemphigus IgG, but not normal nor bullous pemphigoid IgGs, caused a transient increase in intracellular calcium ([Ca++]i) and inositol 1,4,5-trisphosphate (IP3) concentration in cultured DJM-1 cells (a squamous cell carcinoma line). To clarify whether phospholipase C is involved in this process after the antibody binds to the cell surface, we examined the effects of a specific phospholipase C inhibitor (U73122) on the pemphigus IgG-induced increase in [Ca++]i, IP3, PA secretion, and cell-cell detachment in DJM-1 cells. [Ca+2]i and IP3 contents were determined with or without 30-min pre-incubation with U73122 or an inactive analogue (U73343) with fura-2 acetoxymethylester and a specific IP3 binding protein, respectively. PA activity in the culture medium was measured after various incubation periods with pemphigus IgG by two-step amidolytic assay. The detachment of cell-cell contacts was examined by detecting the retraction of keratin filament bundle from cell-cell contact points to the perinuclear region by immunofluorescence microscopy using anti-keratin antibody. Pemphigus IgG immediately increased [Ca++]i and IP3 content. PA activity in the culture medium has also been increased at 24 h after pemphigus IgG was added in association with cell-cell detachment. However, pre-incubation with U73122 (1-10 microM), but not with U73343 (10 microM), dramatically reduced the pemphigus IgG-induced increases in [Ca++]i, IP3, and PA activity and inhibited the pemphigus IgG-induced cell-cell detachment. Both U73122 and U73343 caused no effects on cell viability and IgG binding to the cell surface. These results suggest that phospholipase C plays an important role in transmembrane signaling leading to cell-cell detachment exerted by pemphigus IgG binding to the cell surface.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665907     DOI: 10.1111/1523-1747.ep12319948

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  19 in total

1.  Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity.

Authors:  V T Nguyen; A Ndoye; S A Grando
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Ali Karaouni; Sergei A Grando
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

3.  Adducin is required for desmosomal cohesion in keratinocytes.

Authors:  Vera Rötzer; Andreas Breit; Jens Waschke; Volker Spindler
Journal:  J Biol Chem       Date:  2014-04-07       Impact factor: 5.157

4.  p38MAPK inhibition prevents disease in pemphigus vulgaris mice.

Authors:  Paula Berkowitz; Peiqi Hu; Simon Warren; Zhi Liu; Luis A Diaz; David S Rubenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

5.  Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.

Authors:  M G Mahoney; Z Wang; K Rothenberger; P J Koch; M Amagai; J R Stanley
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering.

Authors:  Kenji Yoshida; Ken Ishii; Atsushi Shimizu; Mariko Yokouchi; Masayuki Amagai; Ken Shiraishi; Yuji Shirakata; John R Stanley; Akira Ishiko
Journal:  J Dermatol Sci       Date:  2016-12-12       Impact factor: 4.563

Review 7.  Immune response in pemphigus and beyond: progresses and emerging concepts.

Authors:  Giovanni Di Zenzo; Kyle T Amber; Beyza S Sayar; Eliane J Müller; Luca Borradori
Journal:  Semin Immunopathol       Date:  2015-11-23       Impact factor: 9.623

Review 8.  A perspective of pemphigus from bedside and laboratory-bench.

Authors:  Yasuo Kitajima; Yumi Aoyama
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

9.  Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence.

Authors:  Mariko Yokouchi; Marwah Adly Saleh; Keiko Kuroda; Takahisa Hachiya; John R Stanley; Masayuki Amagai; Ken Ishii
Journal:  J Invest Dermatol       Date:  2009-04-02       Impact factor: 8.551

10.  An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris.

Authors:  Katja Schulze; Arnaud Galichet; Beyza S Sayar; Anthea Scothern; Denise Howald; Hillard Zymann; Myriam Siffert; Denise Zenhäusern; Reinhard Bolli; Peter J Koch; David Garrod; Maja M Suter; Eliane J Müller
Journal:  J Invest Dermatol       Date:  2011-09-29       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.